These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36361598)

  • 1. Antagonization of OX
    Raïch I; Rebassa JB; Lillo J; Cordomi A; Rivas-Santisteban R; Lillo A; Reyes-Resina I; Franco R; Navarro G
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Methyl-D-aspartate (NMDA) and cannabinoid CB
    Rivas-Santisteban R; Lillo A; Lillo J; Rebassa JB; Contestí JS; Saura CA; Franco R; Navarro G
    Alzheimers Res Ther; 2021 Nov; 13(1):184. PubMed ID: 34749800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB
    Navarro G; Borroto-Escuela D; Angelats E; Etayo Í; Reyes-Resina I; Pulido-Salgado M; Rodríguez-Pérez AI; Canela EI; Saura J; Lanciego JL; Labandeira-García JL; Saura CA; Fuxe K; Franco R
    Brain Behav Immun; 2018 Jan; 67():139-151. PubMed ID: 28843453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and functional interaction between GPR18 and cannabinoid CB
    Reyes-Resina I; Navarro G; Aguinaga D; Canela EI; Schoeder CT; Załuski M; Kieć-Kononowicz K; Saura CA; Müller CE; Franco R
    Biochem Pharmacol; 2018 Nov; 157():169-179. PubMed ID: 29870711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of cannabinoid signaling in microglia by adenosine A
    Franco R; Reyes-Resina I; Aguinaga D; Lillo A; Jiménez J; Raïch I; Borroto-Escuela DO; Ferreiro-Vera C; Canela EI; Sánchez de Medina V; Del Ser-Badia A; Fuxe K; Saura CA; Navarro G
    Glia; 2019 Dec; 67(12):2410-2423. PubMed ID: 31429130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer's Disease.
    Rebassa JB; Capó T; Lillo J; Raïch I; Reyes-Resina I; Navarro G
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2014 Mar; 20(1):29-36. PubMed ID: 24722782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid CB
    López A; Aparicio N; Pazos MR; Grande MT; Barreda-Manso MA; Benito-Cuesta I; Vázquez C; Amores M; Ruiz-Pérez G; García-García E; Beatka M; Tolón RM; Dittel BN; Hillard CJ; Romero J
    J Neuroinflammation; 2018 May; 15(1):158. PubMed ID: 29793509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology.
    Schmöle AC; Lundt R; Toporowski G; Hansen JN; Beins E; Halle A; Zimmer A
    J Alzheimers Dis; 2018; 64(2):379-392. PubMed ID: 29865078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of CB
    Wu J; Hocevar M; Foss JF; Bie B; Naguib M
    Eur J Pharmacol; 2017 Sep; 811():12-20. PubMed ID: 28551012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer's disease mouse model.
    Schmöle AC; Lundt R; Ternes S; Albayram Ö; Ulas T; Schultze JL; Bano D; Nicotera P; Alferink J; Zimmer A
    Neurobiol Aging; 2015 Feb; 36(2):710-9. PubMed ID: 25443294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.
    Wang L; Liu BJ; Cao Y; Xu WQ; Sun DS; Li MZ; Shi FX; Li M; Tian Q; Wang JZ; Zhou XW
    Mol Neurobiol; 2018 Jun; 55(6):4731-4744. PubMed ID: 28717968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Down-Expression of ACE and IDE Exacerbates Exogenous Amyloid-β Neurotoxicity in CB2R-/- Mice.
    Wang L; Shi FX; Xu WQ; Cao Y; Li N; Li M; Wang Q; Wang JZ; Tian Q; Yu LK; Zhou XW
    J Alzheimers Dis; 2018; 64(3):957-971. PubMed ID: 29991137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Expression of Cannabinoid CB
    Lillo J; Raïch I; Silva L; Zafra DA; Lillo A; Ferreiro-Vera C; Sánchez de Medina V; Martínez-Orgado J; Franco R; Navarro G
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077095
    [No Abstract]   [Full Text] [Related]  

  • 15. Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation.
    Savonenko AV; Melnikova T; Wang Y; Ravert H; Gao Y; Koppel J; Lee D; Pletnikova O; Cho E; Sayyida N; Hiatt A; Troncoso J; Davies P; Dannals RF; Pomper MG; Horti AG
    PLoS One; 2015; 10(6):e0129618. PubMed ID: 26086915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A
    Franco R; Rivas-Santisteban R; Casanovas M; Lillo A; Saura CA; Navarro G
    Cells; 2020 Apr; 9(5):. PubMed ID: 32357548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.
    Aso E; Andrés-Benito P; Carmona M; Maldonado R; Ferrer I
    J Alzheimers Dis; 2016; 51(2):489-500. PubMed ID: 26890764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
    Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
    J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CB2 cannabinoid receptor agonist ameliorates novel object recognition but not spatial memory in transgenic APP/PS1 mice.
    Li C; Shi J; Wang B; Li J; Jia H
    Neurosci Lett; 2019 Aug; 707():134286. PubMed ID: 31150731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2013 Nov; 19(1):357-64. PubMed ID: 24408112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.